ChemicalBook >> CAS DataBase List >>varlilumab
varlilumab
- CAS No.
- 1393344-72-3
- Chemical Name:
- varlilumab
- Synonyms
- CDX-1127;varlilumab;Research Grade Varlilumab;Varlilumab (anti-TNFRSF7);Research Grade Varlilumab(DHD72201)
- CBNumber:
- CB83358872
- Molecular Formula:
- Molecular Weight:
- 0
- MDL Number:
- MOL File:
- Mol file
- MSDS File:
- SDS
- TDS File:
- TDS
Last updated:2026-07-27 17:00:41
| storage temp. | Store at -80°C |
|---|---|
| form | Lyophilized Powder |
| color | White to off-white |
| FDA UNII | 0125DUV5XC |
| NCI Drug Dictionary | varlilumab |
varlilumab price
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Biosynth | CLA1048 | Varlilumab | 1393344-72-3 | 1mg | $1512.5 | 2026-06-04 | Buy |
| Biosynth | CLA1048 | Varlilumab | 1393344-72-3 | 5mg | $2646.9 | 2026-06-04 | Buy |
| Biosynth | CLA1048 | Varlilumab | 1393344-72-3 | 10mg | $4331.3 | 2026-06-04 | Buy |
| ChemScene | CS-0926457 | Varlilumab anti-CD27 99.68% | 1393344-72-3 | 1mg | $292 | 2026-06-04 | Buy |
| ChemScene | CS-0926457 | Varlilumab anti-CD27 99.68% | 1393344-72-3 | 5mg | $704 | 2026-06-04 | Buy |
varlilumab Chemical Properties, Uses, Production
Uses
Varlilumab (CDX-1127) is a first-in-class human IgG1 anti-CD27 monoclonal antibody. Varlilumab has an anti-tumor activity[1].
References
[1] Stephen M Ansell, et al. Safety and activity of varlilumab, a novel and first-in-class agonist anti-CD27 antibody, for hematologic malignancies. Blood Adv. 2020 May 12;4(9):1917-1926. DOI:10.1182/bloodadvances.2019001079
varlilumab Preparation Products And Raw materials
Raw materials
Preparation Products
varlilumab Suppliers
Global Suppliers ( 26)
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Shanghai YuanYe Biotechnology Co., Ltd. | 15026964105 | 2881489226@qq.com | China | 89667 | 60 |
| ShangHai Biochempartner Co.,Ltd | 177-54423994 17754423994 | 2853530910@QQ.com | China | 8000 | 62 |
| TargetMol Chemicals Inc. | +1-781-999-5354; +1-00000000000 | marketing@targetmol.com | United States | 32431 | 58 |
| Guangzhou Hongyuan Chemical Co.,Ltd | 15817493340 | 981810490@qq.com | China | 1577 | 58 |
| Wuhan Chemstan Biotechnology Co., Ltd. | 027-65317797 15926423062 | 422450190@qq.com | China | 10305 | 58 |
| Beijing Jin Ming Biotechnology Co., Ltd. | 010-60605840 | psaitong@jm-bio.com | China | 27626 | 58 |
| TargetMol Chemicals Inc. | 4008200310 15002144251 | marketing@tsbiochem.com | China | 24951 | 58 |
| Biolab Reagents | 027-65279366 18108604356 | products@biolabreagent.com | China | 9864 | 58 |
| Wuhan Jingkangen Biomedical Technology Co., Ltd | 13720134139 086-15871494362 13720134139 | orders@jknbiochem.com | China | 7283 | 58 |
| Nantong QuanYi Biotechnology Co., Ltd | 0513-66337626 18051384581 | sales@chemhifuture.com | China | 5985 | 58 |
View Latest Price from varlilumab manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
![]() |
2026-07-27 | Varlilumab
1393344-72-3
|
$222.00-892.00 | 98.65% (SEC-HPLC) | 10g | TargetMol Chemicals Inc. |
-

- Varlilumab
1393344-72-3
- $222.00-892.00
- 98.65% (SEC-HPLC)
- TargetMol Chemicals Inc.
1393344-72-3 (varlilumab) Related Search:
varlilumab
Research Grade Varlilumab(DHD72201)
Varlilumab (anti-TNFRSF7)
CDX-1127
Research Grade Varlilumab
1393344-72-3




